AD/PD 2025
The AD/PD Conference is the main event of the year in the field of neurodegenerative diseases, attracting leading medical and scientific professionals from around the world. AD/PD continues to focus on advances in science and therapy of Alzheimer’s and Parkinson’s Diseases and related neurological disorders.
Stop by Clario’s booth #50 to find out how we can transform your clinical trials with high-quality digital endpoint solutions and operational excellence!
Poster session 1:
Title: Opal sensor equivalency to capture Mobilise-D digital mobility outcomes
Date: TBD
Time: TBD
Author and presenter
Kristen Sowalsky, Ph.D., D.C.
VP, Product Management & Scientific Affairs, Precision Motion
Dr. Kristen Sowalsky is the Vice President of Medical & Scientific Affairs for Precision Motion at Clario. She oversees the scientific advisory, data science, and biostatistical services for digital measures of human movement in clinical trials and academic research. Dr. Sowalsky has 18 combined years of experience in industry, academic/clinical research, and clinical practice. Her academic achievements include a B.S. in kinesiology and exercise science from Appalachian State University, a Doctor of Chiropractic from Logan University, and a Ph.D. in applied neuromechanics from the University of Florida.
Poster session 2:
Title: Breaking boundaries: How digital movement endpoints outperform clinical scales in tracking disease progression in people with Parkinson’s disease
Date: TBD
Time: TBD
Author and presenter
Vrutangkumar V. Shah, Ph.D.
Director, Data Science and Biostatistics, Precision Motion
Dr. Vrutangkumar V. Shah is a scientist with over 13 years of experience in clinical research. He is currently working as the Director of Data Science and Biostatistics at Clario, a global data and technology company that assists with decentralized clinical trials. He consults with sponsors and CROs in developing the Statistical Analysis Plan (SAP) package for Phase I-IV clinical studies. His expertise includes, but is not limited to, data analytics, biostatistics, machine learning, and time-series analysis to develop digital biomarkers for clinical trials.
Meet with us at AD/PD 2025.
Complete this form and we will reach out soon to schedule a time to connect at the event.
If you are a company wishing to collaborate with us, please stop by our booth during the conference to talk with our team.